Posts From December, 2017

Dilute bleach best for disinfecting tonometry equipment

The latest Ophthalmic Technology Assessment explores the most effective method for disinfecting reusable tonometers. Source: AAO

Posted on: Dec 21 2017
By: Saratoga Opthalmology
Leave a response

Study demonstrates feasibility of IOP self-monitoring

Patients with glaucoma can reliably perform self-tonometry using the portable rebound device, according to this prospective study. Source: AAO

Posted on: Dec 20 2017
By: Saratoga Opthalmology
Leave a response

Atropine effective for reducing myopic progression in children

This Ophthalmic Technology Assessment by the Pediatric Ophthalmology/Strabismus Panel reviewed published literature regarding the efficacy of topical atropine for preventing myopic progression in children. Source: AAO

Posted on: Dec 20 2017
By: Saratoga Opthalmology
Leave a response

FDA announces landmark approval of gene therapy for inherited retinal dystrophies

A suite of formerly untreatable, progressively blinding retinal diseases may now be halted or even reversed, thanks to FDA approval of the gene therapy agent, Luxturna. The announcement marks the first U.S. approval of a gene therapy for an inherited disease. Source: AAO

Posted on: Dec 19 2017
By: Saratoga Opthalmology
Leave a response

FDA fast-tracks topical drops for LHON

Stealth BioTherapeutics has gained the fast-track designation for elamipretide, an eye drop aimed at improving mitochondrial function in individuals with Leber’s hereditary optic neuropathy (LHON). Source: AAO

Posted on: Dec 19 2017
By: Saratoga Opthalmology
Leave a response

Vitreous seed classification is predictive of response to intravitreal chemotherapy

This retrospective study evaluated outcomes of retinoblastoma treated with intravitreal melphalan as salvage for vitreous seeding. Source: AAO

Posted on: Dec 19 2017
By: Saratoga Opthalmology
Leave a response

Glaucoma drug Rhopressa snags early FDA approval

Aerie Pharmaceuticals announced that the FDA has approved their once-daily glaucoma drop, Rhopressa, for lowering IOP in patients with open-angle glaucoma or ocular hypertension. Source: AAO

Posted on: Dec 19 2017
By: Saratoga Opthalmology
Leave a response

Week in review: Eclipse souvenirs, cosmetic damage, light therapy

This week a crescent-shaped burn highlights the need for protective eyewear during solar eclipses, and fungal infections fall prey to a rose-colored eyedrop combined with green fluorescent light. Source: AAO

Posted on: Dec 15 2017
By: Saratoga Opthalmology
Leave a response

Novel video goggles offer quick, easy and reliable measurements of ocular deviation

This cross-sectional study examines the utility of strabismus goggles, which feature a head-fixed laser target display and liquid crystal display shutters, for binocular dissociation. Source: AAO

Posted on: Dec 14 2017
By: Saratoga Opthalmology
Leave a response

Alert: Possible shortage of epinephrine for intraocular use

A recent alteration in the formulation of preservative-free epinephrine could lead to a shortage of mydriatic agents for ophthalmologists, according to an alert issued by the American Society of Cataract and Refractive Surgery (ASCRS). Source: AAO